## Abstract The clinical immunology laboratory is often called on to assess risk in pediatric patients with clinical evidence of immunodeficiency and possible human immunodeficiency virus (HIV) exposure while antibody tests are being considered or are underway. Since non–HIV‐related conditions incl
Microencephaly in children congenitally infected with human immunodeficiency virus – a gross-anatomical morphometric study
✍ Scribed by P. B. Kozlowski; J. Brudkowska; M. Kraszpulski; E. A. Sersen; M. A. Wrzolek; A. P. Anzil; C. Rao; H. M. Wisniewski
- Publisher
- Springer-Verlag
- Year
- 1997
- Tongue
- English
- Weight
- 245 KB
- Volume
- 93
- Category
- Article
- ISSN
- 0001-6322
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Background. Reports on lymphoid malignancy and its treatment in children infected with human immunodeficiency virus (HIV) are limited. Methods. Antibodies to Epstein-Barr virus (EBV) were detected by indirect immunofluorescence. DNA was extracted from peripheral blood lymphocytes or biopsy specimen
Uganda offers a unique setting in which to study the effect of human immunodeficiency virus-1 (HIV-1) on cancer. HIV-1 is prevalent there, and cancers which are known to be HIV-associated, such as Kaposi's sarcoma and Burkitt's lymphoma, are endemic. Adults residing in Kampala, Uganda, presenting wi
## BACKGROUND. Burkitt's lymphoma (BL) accounts for 1-2% of all cases of non-